ClinicalTrials.Veeva

Menu

Systemic Sclerosis DIet for GastrointESTinal Symptoms (DIGEST)

University of Michigan logo

University of Michigan

Status

Not yet enrolling

Conditions

Systemic Sclerosis (SSc)

Treatments

Behavioral: Diet 2: Elimination of foods harmful to gut barrier and microbiome
Behavioral: Diet 1: Restriction of fermentable carbohydrates
Behavioral: Diet 3: Regular meal patterns, soluble fiber, and portion control

Study type

Interventional

Funder types

Other

Identifiers

NCT07402226
HUM00285136

Details and patient eligibility

About

This research will evaluate the effect of diets on bloating/distention, assess changes in abdominal pain, and overall gastrointestinal symptom burden in Systemic Sclerosis. The researchers will do this by comparing outcomes of people assigned to 3 different diets. Following the research specifics of the diets will be available upon contact with the details listed below.

Full description

The rationale for keeping the diets (arms/interventions names) vague is it prevents other researchers from using these diets in their studies, minimizes expectation bias of patients (who can have preference for one diet over other) and prevents participants from trying other diets before end of study period in case they don't respond.

Enrollment

60 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Diagnosis of systemic sclerosis (SSc) as per ACR/EULAR classification criteria.• Self-reported moderate to severe gastrointestinal bloating or distension, with a UCLA SCTC-GIT 2.0 bloating Scale score ≥2.00 on (0.00-3.00 scale) at screening.
  • Willingness and ability to comply with dietary intervention and study procedures.
  • Ability to provide informed consent.

Exclusion criteria

  • Diagnosis of inflammatory bowel disease (Crohn's disease or ulcerative colitis) or celiac disease.
  • Use of systemic antibiotics within 4 weeks prior to baseline.
  • History of gastrointestinal surgery (other than cholecystectomy or appendectomy unless in the last 3 months).
  • Severe cognitive impairment or psychiatric illness that would limit ability to follow dietary instructions.
  • Known allergy or intolerance to major components of any of the study diets (e.g., lactose, gluten) unless manageable within diet framework.
  • Current or recent (within 3 months) dietary intervention for managing GI symptoms (e.g. gluten-free diet, low FODMAP diet, etc.).
  • Clinically significant self-reported (≥10 percent weight loss) in the last 3 months
  • BMI less than 20
  • Ongoing tube feeds or TPN
  • Participating in another interventional trial
  • Pregnancy or lactation, or planning pregnancy in the next 6 months

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

60 participants in 3 patient groups

Diet 1: Restriction of fermentable carbohydrates
Experimental group
Treatment:
Behavioral: Diet 1: Restriction of fermentable carbohydrates
Diet 2: Elimination of foods harmful to gut barrier and microbiome
Experimental group
Treatment:
Behavioral: Diet 2: Elimination of foods harmful to gut barrier and microbiome
Diet 3: Regular meal patterns, soluble fiber, and portion control
Experimental group
Treatment:
Behavioral: Diet 3: Regular meal patterns, soluble fiber, and portion control

Trial contacts and locations

1

Loading...

Central trial contact

Rosemary Gedert

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems